Patents by Inventor Bruno Gogly

Bruno Gogly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of oligodendrocytes from oral neuroectodermal stem cells in the repair of the nervous system
    Publication number: 20220002668
    Abstract: This invention concerns a new method for differentiating oral neuroectodermal stem cells (CSO-NE), in particular human gingival neuroectodermal stem cells (CSGh), into oligodendrocytes (OL), and their use in the repair of the nervous system, in particular of head injuries.
    Type: Application
    Filed: November 28, 2019
    Publication date: January 6, 2022
    Inventors: Benjamin FOURNIER, Bruno GOGLY, Catherine MARCHAND-LEROUX, Ali NASSIF, Ihsène TAÏHI
  • Osteoblasts derived from oral neuroectodermal stem cells and their use in jaw repair
    Publication number: 20210403869
    Abstract: The present invention concerns a method for inducing differentiation of neuroectodermal oral stem cells, in particular from FCS osteogenic medium PL osteogenic medium gingival tissue (GSCs), into osteoblasts by culturing them in an optimal serum-free medium supplemented by necessary components such as platelet lysate, growth hormone, heparin, and/or growth factors. The invention method provides osteoblasts for cell therapy, particularly for the restoration of bone defects in maxillary bones.
    Type: Application
    Filed: November 28, 2019
    Publication date: December 30, 2021
    Inventors: Benjamin FOURNIER, Bruno GOGLY, Ali NASSIF, Ihsène TAÏHI, François FERRE
  • METHOD FOR TREATING CANCER
    Publication number: 20180028571
    Abstract: The present invention relates to a method for preventing or treating cancer in an individual comprising administering the individual with a prophylactically or therapeutically effective quantity of a gingival fibroblast-derived product.
    Type: Application
    Filed: October 12, 2017
    Publication date: February 1, 2018
    Inventors: Bruno GOGLY, Antoine LAFONT, Bernard COULOMB, Jean-Jacques LATAILLADE
  • Device for administering cells and cell-therapy methods using said device
    Patent number: 9867971
    Abstract: The present invention relates to a device (2) for cell therapy, said device being designed to be applied on a living tissue and having at least a tight preferably biocompatible first wall (22), designed to form a cavity (24) between said wall and said tissue, and further comprising means (7) to feed a healing substance in said cavity.
    Type: Grant
    Filed: October 9, 2008
    Date of Patent: January 16, 2018
    Assignees: ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, INSERM, UNIVERSITE PARIS DESCARTES
    Inventors: Bruno Gogly, Bernard Coulomb, Antoine Lafont
  • PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF ORTHOPEDIC PATHOLOGIES
    Publication number: 20160256496
    Abstract: The present invention relates to a gingival fibroblast-derived product and its use in methods for the prevention or treatment of orthopedic pathologies in an individual.
    Type: Application
    Filed: March 4, 2016
    Publication date: September 8, 2016
    Inventors: Bruno GOGLY, Antoine LAFONT, Bernard COULOMB
  • METHOD FOR TREATING CANCER
    Publication number: 20160158290
    Abstract: The present invention relates to a method for preventing or treating cancer in an individual comprising administering the individual with a prophylactically or therapeutically effective quantity of a gingival fibroblast-derived product.
    Type: Application
    Filed: February 17, 2016
    Publication date: June 9, 2016
    Inventors: Bruno GOGLY, Antoine LAFONT, Bernard COULOMB, Jean-Jacques LATALLIADE
  • PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ORTHOPEDIC PATHOLOGIES
    Publication number: 20150258146
    Abstract: The present invention relates to a gingival fibroblast-derived product for use in the prevention or treatment of orthopedic pathologies in an individual.
    Type: Application
    Filed: December 10, 2010
    Publication date: September 17, 2015
    Applicant: SCARCELL THERAPEUTICS
    Inventors: Bruno Gogly, Antoine Lafont, Bernard Coulomb
  • Use of gingival fibroblasts for vascular cell therapy
    Patent number: 8609085
    Abstract: The invention relates to the use of gingival fibroblasts for obtaining a cellular composition for treating arterial-remodelling pathology, for example an aneurysm, post-cryoplasty stenosis and restenosis, an aortic dissection or atherosclerosis.
    Type: Grant
    Filed: January 6, 2012
    Date of Patent: December 17, 2013
    Assignees: Universite Paris Decartes, L'assistance Publique—Hopitaux de Paris
    Inventors: Antoine Lafont, Bruno Gogly
  • Method for treating skin wounds
    Patent number: 8303948
    Abstract: The present invention relates to a method for treating a skin wound in an individual, comprising applying to the skin wound of the individual a therapeutically effective quantity of gingival fibroblasts.
    Type: Grant
    Filed: August 7, 2007
    Date of Patent: November 6, 2012
    Assignees: Universite Paris Descartes, Institut National de la Sante et de la Recherche Medicale (INSERM), Assistance Publique—Hopitaux de Paris
    Inventors: Bruno Gogly, Bernard Coulomb, Antoine Lafont
  • USE OF GINGIVAL FIBROBLASTS FOR VASCULAR CELL THERAPY
    Publication number: 20120177613
    Abstract: The invention relates to the use of gingival fibroblasts for obtaining a cellular composition for treating arterial-remodelling pathology, for example an aneurysm, post-cryoplasty stenosis and restenosis, an aortic dissection or atherosclerosis.
    Type: Application
    Filed: January 6, 2012
    Publication date: July 12, 2012
    Applicants: L'assistance Publique - Hopitaux De Paris, Universite Rene Descartes (Paris V)
    Inventors: Antoine Lafont, Bruno Gogly
  • METHOD FOR TREATING CANCER
    Publication number: 20120100111
    Abstract: The present invention relates to a method for preventing or treating cancer in an individual comprising administering the individual with a prophylactically or therapeutically effective quantity of a gingival fibroblast-derived product.
    Type: Application
    Filed: March 8, 2010
    Publication date: April 26, 2012
    Applicant: UNIVERSITE PARIS DESCARTES
    Inventors: Bruno Gogly, Antoine Lafont, Bernard Coulomb, Jean-Jacques Lataillade
  • Use of gingival fibroblasts for vascular cell therapy
    Patent number: 8119122
    Abstract: The invention relates to the use of gingival fibroblasts for obtaining a cellular composition for treating arterial-remodelling pathology, for example an aneurysm, post-cryoplasty stenosis and restenosis, an aortic dissection or atherosclerosis.
    Type: Grant
    Filed: July 1, 2005
    Date of Patent: February 21, 2012
    Assignees: Universite Paris Decartes, L'Assistance Publique-Hopitaux De Paris
    Inventors: Antoine Lafont, Bruno Gogly
  • Culture medium for gingival fibroblasts
    Patent number: 7951593
    Abstract: The present invention relates to a gingival fibroblast culture medium free of animal serum, comprising an animal cell culture medium, free of animal serum, to which is added: from 0.1 ng/ml to 100 ng/ml bFGF, and/or from 1 ?g/ml to 50 ?g/ml insulin.
    Type: Grant
    Filed: March 19, 2008
    Date of Patent: May 31, 2011
    Assignee: Universite Rene Descartes-Paris V
    Inventors: Bruno Gogly, Bernard Coulomb, Antoine Lafont
  • Method for the Cosmetic Treatment of Skin Ageing
    Publication number: 20110097421
    Abstract: The present invention relates to a method for the cosmetic prevention or treatment of skin ageing in an individual, comprising administering to said individual a cosmetically active quantity of a gingival fibroblast-derived product.
    Type: Application
    Filed: March 25, 2009
    Publication date: April 28, 2011
    Inventors: Bruno Gogly, Antoine Lafont, Bernard Coulomb
  • DEVICE FOR ADMINISTERING CELLS AND CELL-THERAPY METHODS USING SAID DEVICE
    Publication number: 20100292670
    Abstract: The present invention relates to a device (2) for cell therapy, said device being designed to be applied on a living tissue and having at least a tight preferably biocompatible first wall (22), designed to form a cavity (24) between said wall and said tissue, and further comprising means (7) to feed a healing substance in said cavity.
    Type: Application
    Filed: October 9, 2008
    Publication date: November 18, 2010
    Inventors: Bruno Gogly, Bernard Coulomb, Antoine Lafont
  • METHOD FOR TREATING SKIN WOUNDS
    Publication number: 20100166711
    Abstract: The present invention relates to a method for treating a skin wound in an individual, comprising applying to the skin wound of the individual a therapeutically effective quantity of gingival fibroblasts.
    Type: Application
    Filed: August 7, 2007
    Publication date: July 1, 2010
    Applicant: UNIVERSITE RENE DESCARTES - PARIS V
    Inventors: Bruno Gogly, Bernard Coulomb, Antoine Lafont
  • CULTURE MEDIUM FOR GINGIVAL FIBROBLASTS
    Publication number: 20090061512
    Abstract: The present invention relates to a gingival fibroblast culture medium free of animal serum, comprising an animal cell culture medium, free of animal serum, to which is added: from 0.1 ng/ml to 100 ng/ml bFGF, and/or from 1 ?g/ml to 50 ?g/ml insulin.
    Type: Application
    Filed: March 19, 2008
    Publication date: March 5, 2009
    Inventors: Bruno GOGLY, Bernard COULOMB, Antoine LAFONT
  • Use of Gingival Fibroblasts for Vascular Cell Therapy
    Publication number: 20080025954
    Abstract: The invention relates to the use of gingival fibroblasts for obtaining a cellular composition for treating arterial-remodelling pathology, for example an aneurysm, post-cryoplasty stenosis and restenosis, an aortic dissection or atherosclerosis.
    Type: Application
    Filed: July 1, 2005
    Publication date: January 31, 2008
    Inventors: Antoine Lafont, Bruno Gogly
  • Use of fucane for regulating the reconstruction of connective tissue
    Patent number: 6559131
    Abstract: The invention concerns the use of fucanes for obtaining medicines for modulating metalloprotease and inhibiting leukocytic elastase. Said medicines help activate collagen synthesis inhibit proliferation of gingival fibroblasts, and activate proliferation of dermal fibroblasts. They are useful in particular for treating periodontal pathologies and dermal lesions.
    Type: Grant
    Filed: November 6, 2000
    Date of Patent: May 6, 2003
    Assignees: Ifremer, Centre National de la Recherche Scientifique, Universite Rene Descartes
    Inventors: Karim Senni, Bernard Pellat, Bruno Gogly, Catherine Blondin, Didier Letourneur, Jacqueline Jozefonvicz, Corinne Sinquin, Sylvia Colliec-Jouault, Patrick Durand